These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38546840)

  • 41. Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration.
    Singh BN; Dedhiya MG; DiNunzio J; Chan P; Kupiec TC; Trissel LA; Laudano JB
    Am J Health Syst Pharm; 2011 Nov; 68(22):2163-9. PubMed ID: 22058102
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Estimation of Caffeine Regimens: A Machine Learning Approach for Enhanced Clinical Decision Making at a Neonatal Intensive Care Unit (NICU).
    Shirwaikar RD
    Crit Rev Biomed Eng; 2018; 46(2):93-115. PubMed ID: 30055527
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Compatibility of esmolol hydrochloride with morphine sulfate and fentanyl citrate during simulated Y-site administration.
    Karnatz NN; Wong J; Kesler H; Baaske DM; Speicher ER
    Am J Hosp Pharm; 1988 Feb; 45(2):368-71. PubMed ID: 2896460
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Physical Compatibility and Chemical Stability of Fentanyl and Naloxone Hydrochloride in 0.9% Sodium Chloride Injection Solution for Patient-Controlled Analgesia Administration.
    Chen P; Chen F; Lei J; Zhou B
    Drug Des Devel Ther; 2020; 14():4179-4187. PubMed ID: 33116406
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Compatibility of drug infusions in the NICU.
    Kalikstad B; Skjerdal A; Hansen TW
    Arch Dis Child; 2010 Sep; 95(9):745-8. PubMed ID: 20570841
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early high-dose caffeine citrate for extremely preterm infants: Neonatal and neurodevelopmental outcomes.
    Firman B; Molnar A; Gray PH
    J Paediatr Child Health; 2019 Dec; 55(12):1451-1457. PubMed ID: 30900326
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Compatibility of Omadacycline With Select Parenteral Products in Simulated Y-site Administration.
    Butler DA; Moolick K; McCray D; Gifford M
    Clin Ther; 2023 Nov; 45(11):1137-1141. PubMed ID: 37777376
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Simulated Y-site compatibility of atosiban acetate with selected intravenous drugs.
    Jiménez-Lozano I; Larrosa-García M; Boix-Montañés A; Bautista SC; Poy MJC
    Eur J Obstet Gynecol Reprod Biol; 2022 Aug; 275():106-109. PubMed ID: 35779331
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Caffeine preserves quiet sleep in preterm neonates.
    Koch G; Schönfeld N; Jost K; Atkinson A; Schulzke SM; Pfister M; Datta AN
    Pharmacol Res Perspect; 2020 Jun; 8(3):e00596. PubMed ID: 32412185
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Physical compatibility of 4% sodium citrate with selected antimicrobial agents.
    Dotson B; Lynn S; Savakis K; Churchwell MD
    Am J Health Syst Pharm; 2010 Jul; 67(14):1195-8. PubMed ID: 20592327
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety profile comparison between extemporaneous and a licensed preparation of caffeine citrate in preterm infants with apnea of prematurity.
    Vatlach S; Arand J; Engel C; Poets CF
    Neonatology; 2014; 105(2):108-11. PubMed ID: 24335098
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration.
    Asempa TE; Avery LM; Kidd JM; Kuti JL; Nicolau DP
    Am J Health Syst Pharm; 2018 Jul; 75(14):1048-1056. PubMed ID: 29895521
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions.
    Trissel LA; Williams KY; Gilbert DL
    J Am Pharm Assoc (Wash); 2000; 40(4):515-9. PubMed ID: 10932461
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Compatibility of gemcitabine hydrochloride with 107 selected drugs during simulated Y-site injection.
    Trissel LA; Martinez JF; Gilbert DL
    J Am Pharm Assoc (Wash); 1999; 39(4):514-8. PubMed ID: 10467816
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Visual, turbidimetric, and particle-content assessment of compatibility of vinorelbine tartrate with selected drugs during simulated Y-site injection.
    Trissel LA; Martinez JF
    Am J Hosp Pharm; 1994 Feb; 51(4):495-9. PubMed ID: 8017415
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Physical compatibility of furosemide in intravenous mixtures for continuous perfusion].
    Pérez Juan E; Maqueda Palau M; Arévalo Rubert M; Ribas Nicolau B; Amorós Cerdá SM
    Enferm Intensiva; 2010; 21(3):96-103. PubMed ID: 20413337
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Caffeine citrate in the NICU.
    Flood E
    Neonatal Netw; 1989 Apr; 7(5):37-9. PubMed ID: 2704353
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of Caffeine Daily Dose With Respiratory Outcomes in Preterm Neonates: A Retrospective Cohort Study.
    Rauf S; Shah S; Bibi Z; Munir R; Jiskani H; Ahmad S; Mir Shah SA; Bibi A; Fasih Ahmad H; Hussain K; Ariff S; Ambreen G
    Inquiry; 2024; 61():469580241248098. PubMed ID: 38666733
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration.
    Chan P; Bishop A; Kupiec TC; Trissel LA; Gole D; Jimidar IM; Vermeersch H
    Am J Health Syst Pharm; 2008 Aug; 65(16):1545-51. PubMed ID: 18693210
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Visual compatibility of oritavancin diphosphate with selected coadministered drugs during simulated Y-site administration.
    Kumar A; Mann HJ
    Am J Health Syst Pharm; 2010 Oct; 67(19):1640-4. PubMed ID: 20852166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.